AI assistant
AbbVie Inc. — Director's Dealing 2013
Feb 19, 2013
29755_dirs_2013-02-19_8f3bd212-aee8-4e39-bf4d-34eaa0ddcfd3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-14
Reporting Person: Schumacher Laura J (EVP, Bus.Dev.,Ext.Aff.&GC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-14 | Common stock, $0.01 par value | A | 71230 | $0.00 | Acquired | 279325 | Direct |
| 2013-02-19 | Common stock, $0.01 par value | F | 15024 | $37.58 | Disposed | 264301 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-14 | Option (right to buy) | $35.88 | A | 145510 | Acquired | 2023-02-13 | Common stock (145510) | Direct |
Footnotes
F1: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 48,504 on 02/14/2014, 48,503 on 02/14/2015, and 48,503 on 02/14/2016.